Literature DB >> 7429503

Alveolar proteinosis as a consequence of immunosuppression. A hypothesis based on clinical and pathologic observations.

C W Bedrossian, M A Luna, R H Conklin, W C Miller.   

Abstract

Eight patients with hematologic malignant disease presented with associated alveolar proteinosis. All but one of these patients also had evidence of opportunistic infections. No explanation for this association could be elicited, but all patients appeared immunosuppressed at the time of their death. Autopsy revealed proteinaceous material or micro-organisms in the alveoli, but the inflammatory response was minimal. Forty cases of opportunistic infections and 22 cases of hematologic malignant disease were found among the patients with alveolar proteinosis reported in the literature. Lungs in these cases also lacked a significant number of inflammatory cells capable of phagocytosis. On the basis of these observations, a hypothesis is formulated to explain alveolar proteinosis as being a result of poor alveolar clearance in immunosuppressed patients.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7429503

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  12 in total

Review 1.  Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis.

Authors:  P L Shah; D Hansell; P R Lawson; K B Reid; C Morgan
Journal:  Thorax       Date:  2000-01       Impact factor: 9.139

Review 2.  Secondary alveolar proteinosis in cancer patients.

Authors:  S Ladeb; J Fleury-Feith; E Escudier; J Tran Van Nhieu; J F Bernaudin; C Cordonnier
Journal:  Support Care Cancer       Date:  1996-11       Impact factor: 3.603

3.  Pulmonary alveolar lipoproteinosis. Remission after antibiotic treatment.

Authors:  B C Gumpert; M R Nowacki; D E Amundson
Journal:  West J Med       Date:  1994-07

4.  Pulmonary alveolar proteinosis: prospective clinical experience in 23 patients for 15 years.

Authors:  K Kariman; J A Kylstra; A Spock
Journal:  Lung       Date:  1984       Impact factor: 2.584

5.  Lipoprotein macroaggregates in bronchoalveolar lavage fluid from patients with diffuse interstitial lung disease: comparison with idiopathic alveolar lipoproteinosis.

Authors:  P L Haslam; D A Hughes; A Dewar; C F Pantin
Journal:  Thorax       Date:  1988-02       Impact factor: 9.139

6.  Diagnostic Pathology of Diffuse Lung Disease in Children.

Authors:  Megan K Dishop
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2010-03       Impact factor: 1.349

7.  Pulmonary alveolar proteinosis. A spontaneous and inducible disease in immunodeficient germ-free mice.

Authors:  T Warner; E Balish
Journal:  Am J Pathol       Date:  1995-04       Impact factor: 4.307

Review 8.  Rare lung disease II: pulmonary alveolar proteinosis.

Authors:  Stephen C Juvet; David Hwang; Thomas K Waddell; Gregory P Downey
Journal:  Can Respir J       Date:  2008 May-Jun       Impact factor: 2.409

9.  Alveolar proteinosis in a patient recovering from Pneumocystis carinii infection: a case report with a review of literature.

Authors:  Petio V Kotov; Vinod B Shidham
Journal:  Cytojournal       Date:  2006-10-12       Impact factor: 2.091

Review 10.  The parallel lives of alpha1-antitrypsin deficiency and pulmonary alveolar proteinosis.

Authors:  Bruce C Trapnell; Maurizio Luisetti
Journal:  Orphanet J Rare Dis       Date:  2013-09-30       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.